See more : Apollo Silver Corp. (APGOF) Income Statement Analysis – Financial Results
Complete financial analysis of Prince Pharmaceutical Co., Ltd. (6935.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Prince Pharmaceutical Co., Ltd., a leading company in the None industry within the None sector.
You may be interested
- Vantage Knowledge Academy Limited (VKAL.BO) Income Statement Analysis – Financial Results
- Writeup Co.,Ltd. (6580.T) Income Statement Analysis – Financial Results
- Allcargo Terminals Limited (ATL.BO) Income Statement Analysis – Financial Results
- Shuifa Energas Gas Co., Ltd. (603318.SS) Income Statement Analysis – Financial Results
- Soma Gold Corp. (SOMA.V) Income Statement Analysis – Financial Results
Prince Pharmaceutical Co., Ltd. (6935.TWO)
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 753.33M | 712.53M | 441.08M | 295.79M | 249.61M |
| Cost of Revenue | 600.23M | 506.74M | 315.59M | 206.82M | 182.02M |
| Gross Profit | 153.09M | 205.79M | 125.49M | 88.98M | 67.59M |
| Gross Profit Ratio | 20.32% | 28.88% | 28.45% | 30.08% | 27.08% |
| Research & Development | 54.67M | 72.05M | 79.21M | 78.22M | 28.54M |
| General & Administrative | 49.27M | 41.53M | 30.76M | 47.13M | 36.09M |
| Selling & Marketing | 23.47M | 24.37M | 16.61M | 14.02M | 12.16M |
| SG&A | 72.74M | 65.90M | 47.38M | 61.15M | 48.35M |
| Other Expenses | 0.00 | 5.16M | -1.67M | 14.14M | -9.31M |
| Operating Expenses | 127.41M | 137.95M | 126.58M | 139.26M | -9.31M |
| Cost & Expenses | 727.55M | 644.68M | 442.17M | 346.07M | -9.31M |
| Interest Income | 1.16M | 221.00K | 29.00K | 166.00K | 0.00 |
| Interest Expense | 10.46M | 8.94M | 7.55M | 5.31M | 2.58M |
| Depreciation & Amortization | 58.56M | 52.35M | 46.22M | 28.37M | 9.30M |
| EBITDA | 88.19M | 125.58M | 43.47M | -7.77M | -3.00K |
| EBITDA Ratio | 11.71% | 17.62% | 9.86% | -2.63% | -3.73% |
| Operating Income | 25.68M | 73.23M | -2.74M | -50.28M | -9.31M |
| Operating Income Ratio | 3.41% | 10.28% | -0.62% | -17.00% | -3.73% |
| Total Other Income/Expenses | -6.51M | -3.65M | -9.21M | 8.84M | 9.32M |
| Income Before Tax | 19.17M | 64.20M | -10.31M | -41.44M | 14.00K |
| Income Before Tax Ratio | 2.54% | 9.01% | -2.34% | -14.01% | 0.01% |
| Income Tax Expense | 3.86M | 12.65M | -2.01M | -7.64M | 5.00K |
| Net Income | 15.31M | 51.55M | -8.30M | -33.80M | 9.00K |
| Net Income Ratio | 2.03% | 7.24% | -1.88% | -11.43% | 0.00% |
| EPS | 0.42 | 1.55 | -0.25 | -1.03 | 0.00 |
| EPS Diluted | 0.42 | 1.55 | -0.25 | -1.03 | 0.00 |
| Weighted Avg Shares Out | 36.45M | 33.19M | 33.19M | 32.72M | 32.06M |
| Weighted Avg Shares Out (Dil) | 36.55M | 33.33M | 33.19M | 32.72M | 32.06M |
No news found for: 6935.TWO
Source: https://incomestatements.info
Category: Stock Reports